Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression (Q40132461)

17 September 2017

Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression (English)

1 reference

17 September 2017

12

Renata Stripecke

0 references

Robert M. Prins

object named as

Robert M Prins

7

0 references

author name string

Takahiro Kimura

1

1 reference

17 September 2017

Richard C Koya

2

1 reference

17 September 2017

Laura Anselmi

3

1 reference

17 September 2017

Catia Sternini

4

1 reference

17 September 2017

He-Jing Wang

5

1 reference

17 September 2017

Begonya Comin-Anduix

6

1 reference

17 September 2017

Emmanuelle Faure-Kumar

8

1 reference

17 September 2017

Nora Rozengurt

9

1 reference

17 September 2017

Yan Cui

10

1 reference

17 September 2017

Noriyuki Kasahara

11

1 reference

17 September 2017

Renata Stripecke

12

1 reference

17 September 2017

1 May 2007

1 reference

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

7

1 reference

17 September 2017

1390-1399

1 reference

Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro

17 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Altering the tropism of lentiviral vectors through pseudotyping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Immune response to green fluorescent protein: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

The control of immunity and tolerance by dendritic cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

B cells as antigen presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Stem cells engineered to express self-antigen to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300180

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300180

1 reference

17 September 2017

1 reference